AzTrials
AzTrials

Breast Cancer Awareness and BSE in Visually Impaired WomenNCT06274762

Visually Impaired Women Model-based Cancer Education and Breast Self-examination

A study testing Training and BSE application on a model in people with Breast Cancer Awareness and BSE in Visually Impaired Women, run by Marmara University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of our study was to raise awareness among visually impaired women, who are in the vulnerable group, about breast cancer, which ranks first among female cancers, and to teach breast self-examination. Read more about this study

Who is it for?
Ages 20 to 69 years, women onlyHealthy volunteers can take part
What is being tested?
Training and BSE application on a model
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Apr 2024to 31 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 69 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Being visually impaired
  • Volunteering to participate in research
  • Not having any disability other than visual impairment
  • Being knowledgeable individuals who can communicate
  • Not being diagnosed with breast cancer

Who cannot join

  • Not being willing to participate in the research
  • Not filling out research-related forms completely
  • Abandoning the study at any time during the research

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Marmara University

    Istanbul

    Marmara University, sevalsaray.demir@gmail.com

    Seval Saraydemir Kıromeroglu

Other trials in Turkey (Türkiye)

About this study

Official title: Breast Cancer Awareness of Women With Visual Impairment and Self-administered Health Belief Model-Based Education Effect on Breast Examination Skills

The aim of our study was to raise awareness among visually impaired women, who are in the vulnerable group, about breast cancer, which ranks first among female cancers, and to teach breast self-examination.

Read the detailed description

Cancer ranks second after cardiovascular diseases among the causes of death in the world and in our country and it is predicted that by 2030 this situation will change due to changing living and environmental conditions and cancer will take the first place. Breast cancer is the most common type of cancer among female cancers. Breast cancer is a type of cancer that can be prevented and treated if diagnosed early. For this reason, screening programs have been developed to prevent breast cancer and these screening programs include breast self-examination (BSE), clinical breast examination and mammography. These screening programs, which are also accepted in our country, include all women between the ages of 20-69. should be included. However, 11% of breast cancer cases are diagnosed at a distant stage. Disability for women, it affects their access to health services; people's perceptions of disability, inappropriate health services facilities and equipment, stereotypes and discrimination, economic inadequacy, negative treatment from staff, unequal allocation of time and money within the household for their care, limited health service coverage and lack of disability-related education, sensitization or recognition of women as a person in need of sexual and reproductive health care impede women's seeking, use and access to health care. However, every woman has the right to regular gynecological examinations and good care. In our study, the breast cancer awareness of visually impaired women and the effect of training based on the health belief model on their ability to perform breast self-examination will be evaluated. The population of the study consists of visually impaired women between the ages of 20-69. The sample of the study was calculated based on Cohen's effect size study.

Taking d (effect size) as 0.8, α= 0.05 and power as 0.95, the experimental group was determined as 42 and the control group as 42 people. G power 3.1 program was used in the calculations. Considering the problems that may occur during the research process, 45 in the experimental group and 45 in the control group, a total of 90 people constitute the sample of the study. As data collection tools; a questionnaire form including sociodemographic data created by the researchers, Champion's Health Belief Model Scale and KKMM Skill Checklist on Model will be used. The data will be analyzed with descriptive analyses in SPSS program and pre-test - post-test comparative analyses will be performed to determine the effectiveness of the intervention.

Being tested
Training and BSE application on a model
Keywords
Visually impaired women, breast self-examination, breast cancer
Medical subject headings
Breast Self-Examination, Breast Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Training and BSE application on a modelOther

    Also called Health Belief Model Based Education

    A breast cancer awareness training designed according to the headings of sensitivity, seriousness, benefit, obstacle perception, health motivation and self-efficacy, which are the steps of the health belief model, followed by applied BSE on a model.

Study groups in NCT06274762
Study groupRoleWhat they receive
Experimental groupExperimentalA pre-test will be conducted to determine socio-demographic data and to assess breast cancer awareness (champion health belief model scale). Experimental and control groups will be formed. The 45 people in the experimental group will be divided into 5 groups of 8 people. Each group will receive 45 minutes of theoretical training and 60 minutes of BSE application and will be explained and applications will be provided on the model. Question - Answer - 20 minutes will be allocated for feedback. 5 groups will be allocated one day each.4 weeks after the training, the experimental group will be called again in 5 groups and the champion health belief model scale will be repeated, they will be asked to perform the BSE application on the model and evaluation will be made according to the BSE evaluation form prepared by the researcher. 6 months after the study, the whatsapp group will be questioned about whether individuals have BSE.
Receives: Other: Training and BSE application on a model
Control GroupActive comparatorA pre-test will be conducted to determine socio-demographic data and to assess breast cancer awareness (champion health belief model scale). Experimental and control groups will be formed.The control group will not be intervened until the study is over.
Receives: Other: Training and BSE application on a model

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Champion health belief model scale

    The scale evaluates the individual's judgment about breast cancer and general health, including "sensitivity", "importance/seriousness" and "health motivation", "obstacles", "benefits" regarding BSE, "self-efficacy/confidence", "benefits" regarding mammography. " and "obstacles" dimensions. Which dimensions of the scale will be used varies depending on the purpose of the study and the characteristics of the study group. A 5-point Likert type scaling method ranging from 1 to 5 was used to evaluate the scale. Each dimension of the scale is evaluated separately and is not combined into a single total score. Accordingly, points equal to the number of dimensions used are obtained for each individual. Although completing the scale depends on which dimensions are used, it takes approximately 12-15 minutes when all of them are used. The scale consists of 36 items and 6 factors.

    Measured: two weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2024
  2. Study start1 Apr 2024 (estimated)
  3. Primary completion31 Mar 2025 (estimated)
  4. Study completion31 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Crossover
Model description
There is an experimental group of 45 visually impaired women aged 20-69 and a control group of 45. Randomization was not possible. Blinding could not be done.
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06274762
Sponsor's protocol ID
MARU-SBF-ROKÇ-01
Status last verified
Feb 2024
First submitted
16 Feb 2024
Last updated
23 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Training and BSE application on a model in people with Breast Cancer Awareness and BSE in Visually Impaired Women, run by Marmara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Champion health belief model scale (time frame: two weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in